Erasca, Inc.
ERAS
$10.46
$0.080.77%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/14/2026
-
SeekingAlpha
5/14/2026
-
Seeking Alpha: Transcripts
5/13/2026
-
Simply Wall St
5/13/2026
-
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS
5/12/2026
-
Globe Newswire
5/12/2026
-
The Cerbat Gem
5/12/2026
-
TipRanks Financial Blog
5/11/2026
-
Seeking Alpha - Healthcare
5/11/2026
-
Seeking Alpha - Long Ideas
5/11/2026
-
Seeking Alpha - Healthcare
5/11/2026
-
Globe Newswire
5/11/2026
-
Seeking Alpha - Healthcare
5/11/2026
-
Globe Newswire
5/10/2026
-
Globe Newswire
5/10/2026
-
Yahoo! Finance: News
5/10/2026
-
Insider Monkey
5/7/2026
-
Simply Wall St
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS
5/7/2026
-
PR Newswire
5/7/2026
-
Simply Wall St
5/6/2026
-
Globe Newswire
5/6/2026
-
MarketBeat
5/6/2026
-
Simply Wall St
5/5/2026
-
Insider Monkey
5/5/2026
-
Yahoo! Finance: News
5/5/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, May 11, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 465 6511
Address
3115 Merryfield Row
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company’s...
more